Antioxidant, lipid-lowering and antiplatelet activity of tomato (Solanum lycopersicum L.) and the effect of its processing and storage;Actividad antioxidante, hipolipemiante y antiplaquetaria del tomate (Solanum lycopersicum L.) y el efecto de su procesamiento y almacenaje

Revista Chilena de Nutricion

Volumn 37, Issue 4, 2010, Pages 524-533

  Ivan Palomo G ^a   Eduardo Fuentes, Q ^a   Gilda Carrasco, S ^a   Daniel Gonzalez R ^a   Moore Carrasco, Rodrigo ^a  

^a UNIVERSIDAD DE TALCA   (Chile)

Author keywords

Antioxidant; Antiplatelet; Cardiovascular diseases; Lipid lowering; Patents; Processing; Tomatoes

Indexed keywords

LYCOPERSICON ESCULENTUM; SOLANUM;

EID: 79951750537     PISSN: 07177518     EISSN: None     Source Type: Journal    
DOI: 10.4067/s0717-75182010000400014     Document Type: Review

References (91)

1. Brown D. Mokdad A. Walke H. As'ad M. Al-Nsour M. Zindah M. Arqoob K. Belbeisi A. Projected Burden of Chronic. Noncommunicable Diseases in Jordan. Preventing Chronic Dis. 2009; 6:1-3.
2. WHO. World Health Organization. Informe sobre la salud en el mundo. Technical Report Series. Geneve. 2002.
3. Drouet L. Atherothrombosis as a systemic disease. Cerebrovascular Dis. 2000; 13:1-6.
4. Gimbrone M., Topper J., Nagel T., Anderson K., Garcia-Cardena G., Endothelial dysfunction, hemodynamic forces, and atherogenesis. Ann N Y Acad Sci. 2000; 902:230-239; discussion 239-240.
5. Badimon L., Vilahur G., Platelets, arterial thrombosis and cerebral ischemia. Cerebrovasc Dis. 2007; 24:30-39.
6. Llodrá J. Angeli V. Liu J. Trogan E. Fisher E. Randolph G. Emigration of monocyte-derived cells from atherosclerotic lesions characterizes regressive, but not progressive, plaques. Proc Nat Acad Sci. 2004; 101:11779-117784.
7. Libby P. Ridker P. Maseri A. Inflammation and atherosclerosis. Circulation 2002; 105: 1135-1143.
8. Spagnoli L. Bonanno E. Sangiorgi G. Mauriello A. Role of inflammation in atherosclerosis. J Nuclear Med. 2007; 48:1800-1815.
9. Palomo I. Toro C. Alarcón M. Rol of the platelets in the pathophysiology of atherosclerosis. Molecular Med Reports. 2008; 1:179-184.
10. Rodriguez C., Raposo B., Martinez-Gonzalez J., Casani L., Badimon L., Low density lipoproteins downregulate lysyl oxidase in vascular endothelial cells and the arterial wall. Arteriosclerosis, Thrombosis Vascular Biol. 2002; 22:1409-1414.
11. Palomo I. Moore-Carrasco R. Alarcon M. Rojas A. Espana F. Andres V. Gonzalez-Navarro H. Pathophysiology of the proatherothrombotic state in the metabolic syndrome. Frontiers Bioscience 2010; 2:194-208.
12. Vega J. Bedregal P. Jadue L. Delgado I. Equidad de género en el acceso a la atención de salud en Chile. Rev Med Chil. 2003; 131:669-678.
13. Palomo I. Icaza G. Mujica V. Núñez L. Leiva E. Vásquez M. Alarcón M. Moyano E. Prevalencia de factores de riesgo cardiovascular clásicos en población adulta de Talca, Chile, 2005. Rev Med Chile. 2007; 135:904-912.
14. Palomo I. Gutierrez C. Alarcón M. Jaramillo J. Segovia F. Leiva E. Mujica V. Icaza G. Díaz N. Carrasco-Moore R. Increased Concentration of Plasminogen Activator Inhibitor-1 and fibrinogen in Individuals with metabolic syndrome. Molecular Med Rep. 2009; 2:253-257.
15. Mujica V., Leiva E., Icaza G., Diaz N., Arredondo M., Moore-Carrasco R., Orrego R., Vásquez M., Palomo I., Evaluation of metabolic syndrome in adults of Talca city, Chile. Nutr J. 2008; 7:1-6.
16. Palomo I. Torres G. Alarcón M. Maragaño P. Leiva E. Mujica V. Alta prevalencia de factores de riesgo cardiovascular clásicos en una población de estudiantes universitarios de la región centro-sur de Chile. Rev Esp Cardiol. 2006; 59:1099-1105.
17. WHO. World Health Organization. Diet, nutrition and the prevention of chronic diseases. Report of a joint WHO/FAO expert consultation. Technical Report Series 2003; 916:34-38.
18. Dauchet L. Amouyel P. Hercberg S. Dallongeville J. Fruit and vegetable consumption and risk of coronary heart disease: a meta-analysis of cohort studies. J Nutr. 2006; 136: 2588-2593.
19. Mink P. Scrafford C. Barraj L. Harnack L. Hong C. Nettleton J. Jacob D. Flavonoid intake and cardiovascular disease mortality: a prospective study in postmenopausal women. Am J Clin Nutr. 2007; 85:895-909.
20. Sesso H. Liu S. Gaziano J. Buring J. Dietary lycopene, tomato-based food products and cardiovascular disease in women. J Nutr 2003; 133:2336-23341.
21. Torres C. Guzmán L. Moore-Carrasco R. Palomo I. Efecto antitrombótico, una característica poco conocida de las frutas y hortalizas. Rev Chil Nutr. 2008; 35:10-17.
22. Rissanen T. Voutilainen S. Nyyssonen K. Salonen R. Kaplan G. Salonen J. Serum lycopene concentrations and carotid atherosclerosis: the Kuopio ischaemic heart disease risk factor study. Am J Clin Nutr. 2003; 77:133-138.
23. Nuez, F. El cultivo del tomate. Mundi-Prensa. Barcelona, 1995.
24. INE. Instituto Nacional de Estadística. VI Censo Nacional Agropecuario. Santiago (Chile) 1997.
25. Dorais M. Ehret D. Papadopoulos A. Tomato (Solanum lycopersicum) health components: from the seed to the consumer. Phytochemistry Reviews 2008; 7:231-250.
26. Guil-Guerrero J. Rebolloso-Fuentes M. Nutrient composition and antioxidant activity of eight tomato (Lycopersicon esculentum) varieties. J Food Composition Analysis 2009; 22:123-129.
27. Porrini M. Riso P. Brusamolino A. Berti C. Guarnieri S. Visioli F. Daily intake of a formulated tomato drink affects carotenoid plasma and lymphocyte concentrations and improves cellular antioxidant protection. British J Nutr. 2005; 93:93-99.
28. Adalid A. Roselló S. Nuez F. Mejora de la calidad nutritiva en tomate: búsqueda de nuevas fuentes de variabilidad con alto contenido en carotenoides y vitamina C. Soc Española Ciencias Hortícolas 2007; 48:121-124.
29. Cámara H. Innovation in processing tomato: the lab and the field. Acta Horticulturae 2007; 758:97-102.
30. Saavedra D. Escaff G. Cortacáns P. Ruiz-Tagle C. Recent Development in Processing Tomato Production in Chile. Acta Horticulturae 2006; 724:335-338.
31. Saavedra D. González M. Seminario internacional: Producción de tomate para procesamiento. Serie Actas Instituto de Investigaciones Agropecuarias. Santiago (Chile) 2006.
32. Lugasi A. Hovari J. Bíró L. Brandt S. Helyes L. Factors influencing lycopene content of foods, and lycopene intake of Hungarian population. Magyar Onkologia. 2004; 48:131-136.
33. Gitenay D. Lyan B. Rambeau M. Mazur A. Rock E. Comparison of lycopene and tomato effects on biomarkers of oxidative stress in vitamin E deficient rats. European J Nutr. 2007; 46:468-475.
34. Hadley C. Clinton S. Schwartz S. The consumption of processed tomato products enhances plasma ly copene concentrations in association with a reduced lipoprotein sensitivity to oxidative damage. J Nutr. 2003; 133:727-732.
35. Agarwal S. Rao A. Tomato lycopene and its role in human health and chronic diseases. Canadian Med Assoc J. 2000; 163:739-744.
36. Visioli F. Riso P. Grande S. Galli C. Porrini M. Protective activity of tomato products on in vivo markers of lipid oxidation. European J Nutr. 2003; 42:201-206.
37. Palomo I., Gutiérrez M., Astudillo L., Rivera C., Torres C., Guzmán L., Moore-Carrasco R., Carrasco G Efecto antioxidante de frutas y hortalizas de la zona central de Chile. Rev Chil Nutr. 2009; 36:152-158.
38. Hussein L. Medina A. Barrionnevo A. Lammuela-Raventos R. Andres-Lacueva C. Normal distribution of urinary polyphenol excretion among Egyptian males 7-14 years old and changes following nutritional intervention with tomato juice (Lycopersicon esculentum). Internat J Food Sci Nutr. 2009; 60:302-311.
39. George B. Kaur C. Khurdiya D. Kapoor H. Antioxidants in tomato (Lycopersium esculentum) as a function of genotype. Food Chem. 2004; 84: 45-51.
40. Riso P. Visioli F. Erba D. Testolin G. Porrini M. Lycopene and vitamin C concentrations increase in plasma and lymphocytes after tomato intake. Effects on cellular antioxidant protection. European J Clin Nutr. 2004; 58:1350-1358.
41. Porrini M. Riso P. Lymphocyte lycopene concentration and DNA protection from oxidative damage is increased in women after a short period of tomato consumption. J Nutr. 2000; 130:189-192.
42. Porrini M. Riso P. Oriani G. Spinach and tomato consumption increases lymphocyte DNA resistance to oxidative stress but this is not related to cell carotenoid concentrations. European J Nutr. 2002; 41:95-100.
43. Basu A. Imrhan V. Tomatoes versus lycopene in oxidative stress and carcinogenesis: conclusions from clinical trials. European J Clin Nutr. 2006; 61:295-303.
44. Agarwal S. Rao A. Tomato lycopene and low density lipoprotein oxidation: a human dietary intervention study. Lipids 1998; 33:981-984.
45. Ortiz H. Giacopini M. Alfonso P. Bosch V. Efecto antioxidante del tomate (Lycopersicum esculentum Mill) en la lipoproteína de alta densidad (HDL) y en los microsomas hepático de la rata. Archivos Venezolanos de Farmacología y Terapéutica 2003; 22:46-52.
46. Sahin N. Orhan C. Tuzcu M. Sahin K. Kucuk O. The Effects of Tomato Powder Supplementation on Performance and Lipid Peroxidation in Quail. Poultry Sci. 2008; 87:276-283.
47. Bustamante L. Efecto antitrombótico del consumo de tomates y aceite de oliva extra virgen en un modelo animal. Facultad de Ciencias De La Salud, Escuela de Tecnología Médica Universidad de Talca, Talca, 2009, p 59.
48. Rubio P. Efecto antitrombótico in vivo del tomate. Facultad de Ciencias De La Salud, Escuela de Tecnología Médica Universidad de Talca, Talca, 2009, p 56.
49. Jacob K. Periago M. Böhm V. Berruezo G. Influence of lycopene and vitamin C from tomato juice on biomarkers of oxidative stress and inflammation. British J Nutr. 2008; 99:137-146.
50. Silaste M., Alfthan G., Aro A., Kesäniemi A., Hörkkö S., Tomato juice decreases LDL cholesterol levels and increases LDL resistance to oxidation. British J Nutr. 2007; 98:1251-1258.
51. Madrid E. Vásquez D. Leyton F. Mandiola C., El consumo de Lycopersicum esculentum podría aumentar lipoproteínas de alta densidad (HDL) y disminuir el estrés oxidativo a corto plazo. Rev Méd Chil. 2006; 134:855-862.
52. Yamamoto J. Taka T. Yamada K. Ijiri Y. Murakami M. Hirata Y. Naemura A. Hashimoto M. Yamashita T. Oiwa K. Seki J. Suganuma H. Inakuma T. Yoshida T. Tomatoes have natural anti-thrombotic effects. Br J Nutr. 2003; 90:1031-1038.
53. Palomo I. Torres C. Guzmán L. et al. Actividades antitrombótica y antioxidante, in vitro, de extractos de frutas y hortalizas que se consumen en la región central de Chile. XXV Congreso de la Sociedad Española de Trombosis y Hemostasis, 2009.
54. Dutta-Roy A. Crosbie L. Gordon M. Effects of tomato extract on human platelet aggregation in vitro. Platelets 2001; 12:218-227.
55. O'Kennedy N. Crosbie L. Van Lieshout M. Broom J. Webb D. Dutta-Roy A. Effects of antiplatelet components of tomato extract on platelet function in vitro and ex vivo: a time-course cannulation study in healthy humans. Am J Clin Nutr. 2006; 84:570-579.
56. O'Kennedy N., Crosbie L., Whelan S., Luther V., Broom J., Webb D., Dutta-Roy A., Effects of tomato extract on platelet function: a double-blinded crossover study in healthy humans. Am J Clin Nutr. 2006; 84:561-569.
57. Lazarus S. Garg M. Tomato extract inhibits human platelet aggregation in vitro without increasing basal cAMP levels. Internat J Food Sci Nutr. 2004: 55:249-256.
58. Fernández C. Pitre A. LLobregat M. Rondón Y. Evaluación del Contenido de Licopeno en Pastas de Tomate Comerciales. Información Tecnológica. 2007; 18:31-38.
59. Re R. Bramley P. Rice-Evans C. Effects of food processing on flavonoids and lycopene status in a Mediterranean tomato variety. Free Radical Res. 2002; 36:803-810.
60. Djuric Z. Powell L. Antioxidant capacity of lycopene-containing foods. Internat J Food Sci Nutr. 2001; 52:143-149.
61. Nguyen M. Schwartz S. Lycopene: chemical and biological properties. Food Technol. 1999; 53:38-45.
62. Shi J. Maguer M. Lycopene in tomatoes: chemical and physical properties affected by food processing. Crit Rev Biotechnol. 2000; 20:293-334.
63. Garcia-Alonso F. Bravo S. Casas J. Perez-Conesa D. Jacob K. Periago M. Changes in Antioxidant Compounds during the Shelf Life of Commercial Tomato Juices in Different Packaging Materials. J Agric Food Chem. 2009; 57:6815-6822.
64. Boileau T. Boileau A. Erdman J. Bioavailability of all-trans and cis-isomers of lycopene. Experiment Biol Med. 2002; 227:914-991
65. Gartner C. Stahl W. Sies H. Lycopene is more bioavailable from tomato paste than from fresh tomatoes. Am J Clin Nutr. 1997; 66:116-122.
66. Agarwal A. Shen H. Agarwal S. Rao A. Lycopene content of tomato products: its stability, bioavailability and in vivo antioxidant properties. J Med Food. 2001; 4:9-15.
67. Van Het Hof K., De Boer B., Tijburg L., Lucius B., Zijp I., West C., Hautvast J., Weststrate J., Carotenoid bioavailability in humans from tomatoes processed in different ways determined from the carotenoid response in the triglyceride-rich lipoprotein fraction of plasma after a single consumption and in plasma after four days of consumption. J Nutr. 2000; 130:1189-96.
68. Unlu N. Bohn T. Francis D. Nagaraja H. Clinton S. Schwartz S. Lycopene from heat-induced cis-isomer-rich tomato sauce is more bioavailable than from all-trans-rich tomato sauce in human subjects. British J Nutr. 2007; 98:140-146
69. Candelas-Cadillo M. Alanís-Guzmán M. Bautista-Justo M. Del Río-Olague F. García-Díaz C. Contenido de licopeno en jugo de tomate secado por aspersion lycopene content in spray-dried tomato juice. Rev Mexicana Ingeniería Quím. 2005; 4:299-307.
70. Seybold C. Frohlich K. Bitsch R. Otto K. Bohm V. Changes in contents of carotenoids and vitamin E during tomato processing. J Agric Food Chem. 2004; 52:7005-7010.
71. Takeoka G. Dao L. Flessa S. Gillespie D. Jewell W. Huebner B. Bertow D. Ebeler S. Processing effects on lycopene content and antioxidant activity of tomatoes. J Agric Food Chem 2001; 49:3713-3717.
72. Chang C. Liu Y. Study on lycopene and antioxidant contents variations in tomatoes under air-drying process. J Food Sci. 2007; 72:E532-E540.
73. Dewanto V. Wu X. Adom K. Liu R. Thermal processing enhances the nutritional value of tomatoes by increasing total antioxidant activity. J Agric Food Chem. 2002; 50:3010-314.
74. Richelle M. Bortlik K. Liardet S. Hager C. Lambelet P. Baur M. Applegate L. Offord E. A food-based formulation provides lycopene with the same bioavailability to humans as that from tomato paste. J Nutr. 2002; 132:404-408.
75. Gahler S. Otto K. Bohm V. Alterations of vitamin C, total phenolics, and antioxidant capacity as affected by processing tomatoes to different products. J Agric Food Chem. 2003; 51: 7962-7968.
76. Reboul E. Borel P. Mikail C, Abou L., Charbonnier M. Caris-Veyrat C. Goupy P. Portugal H. Lairon D. Amiot M. Enrichment of Tomato Paste with 6% Tomato Peel Increases Lycopene and {beta}-Carotene Bioavailability in Men. J Nutr. 2005; 135:790-794.
77. Ordóñez A. Balanza M. Martín F. Flores C. Estabilidad del Carotenoide Licopeno en Tomates en Conserva. Información Tecnológica 2009; 20:31-37.
78. Cohn W. Thürmann P. Tenter U. Aebischer C. Schierle J. Schalch W. Comparative multiple dose plasma kinetics of lycopene administered in tomato juice, tomato soup or lycopene tablets. European J Nutr. 2004; 43:304-312.
79. Shi J. Dai Y. Kakuda Y. Mittal G. Xue S. Effect of heating and exposure to light on the stability of lycopene in tomato puree. Food Control 2008; 19:514-520.
80. Zapata L. Gerard L. Davies C. Schvab M. Estudio de los componentes antioxidantes y actividad antioxidante en tomates. Ciencia, Docencia y Tecnología. 2007; 35:175-193.
81. Xie L. Ying Y. Use of near-infrared spectroscopy and least-squares support vector machine to determine quality change of tomato juice. J Zhejiang Univ Sci B 2009; 10:465-471.
82. Iniesta M., Perez-Conesa D., Garcia-Alonso J., Ros G., Periago M., Folate Content in Tomato (Lycopersicon esculentum). Influence of Cultivar, Ripeness, Year of Harvest, and Pasteurization and Storage Tem peratures. J Agric Food Chem. 2009; 57:4739-4745.
83. Weisburger J. Evaluation of the evidence on the role of tomato products in disease prevention. Experiment Biol Med. 1998; 218:140-143.
84. Medina J. Product for Use in the Prevention and Treatment of Cardiovascular Diseases, Cancer and Chronic Inflammatory Diseases. Organización Mundial de la Propiedad Intelectual. Estados Unidos, 2008.
85. Waliszewski K. Blasco G. Propiedades nutraceúticas del licopeno. Salud Pública de México 2010; 52:254-265.
86. Etminan M. Takkouche B. Caamaño-Isorna F. The role of tomato products and lycopene in the prevention of prostate cancer: a meta-analysis of observational studies. Cancer Epidemiology Biomarkers & Prevent 2004; 13:340-345.
87. Giovannucci E. Tomatoes, tomato-based products, lycopene, and cancer: review of the epidemiologic literature. J Nat Cancer Inst. 1999; 91:317-331.
88. Dutta-Roy A. Antithrombotic agents Provexis Limited. Estados Unidos, 2005.
89. O'Kennedy N. Crosbie L. Therapeutic uses of tomato extracts. Provexis natural products limited. Estados Unidos, 2009.
90. Palomo I. Moore-Carrasco R. Alarcón M. Rojas A. Mujica V. Hasbun S. Fisiopatología del estado protrombótico en el síndrome metabólico. Acta Méd Colomb. 2009; 34:80-84.
91. Petyaev I. Bash G. Lycopene for the treatment of metabolic dysfunction Cammedica limited. Estados Unidos, 2009.